Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:974 (22 April), doi:10.1136/bmj.332.7547.974-a
| The first 150 words of the full text of this article appear below. |
EDITORBrown makes a case for making treatment choices in patients with hypertension on the basis of ethnic group.1 However, it is unclear if his use of the term ethnic group refers to skin pigmentation or common ancestry. Common ancestry would certainly be difficult to accurately determine from the clinical encounter, and the usefulness of skin pigmentation would depend on the homogeneity of biological characteristics in the ethnic group.
For black people such homogeneity remains to be proved. The black population is highly heterogeneous, in a genetic and geographical context. Most of the available knowledge on the pathophysiological profile in black patients with hypertension is based on the well researched North American black population.2 African Americans are mostly descended from west, central, and southeast African ancestors, with whom they may share genetic traits. However, they may not necessarily share the same heritage with Africans from other parts of the
Onyebuchi E Okosieme, specialist registrar
Centre for Endocrine and Diabetes Science, School of Medicine, Cardiff University, Cardiff CF14 4XN okosiemeoe@cf.ac.uk